By providing and the facilitate research tools that are original, very perfect quality and always with timely, STEMCELL Technologies is committed to supporting the stem cell and many other areas of the life science research worldwide today. Nowadays there are plenty of products that are available by the STEMCELL's Technologies with the cell disjointing and particular media. The Cytokines, the antibodies, the tissue culture reagents, and the most important services together with the contract assays, the proficiency testing, and the training are some of the products that are offered for a large collection of research functions, and are complement by a diverse array.

When thinking about the stem cell biology development of products, the STEMCELL Technologies is a world leader and has worked to standardize the field through the Global Proficiency Testing Program. Contributing Contract Assay Services by the research society though the joining the stem cell biology and the team of experts in scientific hematopoiesis and STEMCELL Technologies industry standard reagents, they are very confident to help the organizations in environmental toxicant testing, drug development and the agrochemical production.

STEMCELL Technologies Contract Services Team has succeeded in gaining the trust in worldwide hospitals, organizations of researching, and the pharmaceutical and biotech companies to perform their assays. This Contract Services Team mainly considering in goals and needs that the customer required from them, by performing the experiments and the custom design. Following GLP protocols with their very newly built level 2 lab Contract Services Team performed their all assays. They provide a suitable written report to get the submission of FDA by interpret resulting data and analyze it perfectly. And another thing is that this Contract Services Team always guarantee completely about customer confidentiality and to the highest professional quality standards.

In the meantime, that the one thing that was not good for STEMCELL Technologies is that, the cost has increased expansively of developing brand new products. So they realize that, rather than delivering a biomedical revolution, as some expected it is necessary to concern about the progress of original goods and the major treatments could be rust together.

So according to the FDA, the major problem is that, with the great progress in the essential sciences, the practical sciences required for medical manufactured goods improvement have not kept speed. The modern science hasn’t being used to lead the technology improvement procedure at the equivalent way that it is speed up the technology researching procedure.
In the medical technology, the effectiveness and the product safety is the two major terms that are used to measure the performance. So to obtain primarily much enhanced responses regarding the how effectiveness and the safety of new products that can be demonstrated, it is not enough to applied scientific effort to generate the new tools.

At the time, for the stem cell research with the innovative technologies in the area of devices particularly, the assays, the release processes, the commercially scalable processes and developing applications and the industrial applications, the research community is beginning to respond to the FDAs.